Development and Validation of an LC–MS/MS Method for Quantitative Determination of Tacrolimus in Mouse Serum
Biomedical Chromatography · 2026-05 · 40 (5)
DOI: 10.1002/bmc.70437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 08.04.2026. Verfasst von Xiaoming Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mass Spectrometry Core Facility, Division of Basic Science & Transitional Research, Department of Obstetrics & Gynecology, University of Texas Medica…. Hauptthemen laut MEDLINE: Tacrolimus, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Immunosuppressive Agents. Die Arbeit nennt 29 Literaturangaben. Gefördert von: NICHD NIH HHS, NIH-NCATS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Tacrolimus, a potent immunosuppressant with a narrow therapeutic index, is a known substrate of P‐glycoprotein (P‐gp), a key efflux transporter involved in drug disposition. Accurate and sensitive quantification of tacrolimus in small‐volume mouse serum is essential not only for pharmacokinetic studies but also for evaluating in vivo P‐gp functional activity, particularly in pregnancy‐related drug transport research. Tacrolimus was extracted using methyl tert‐butyl ether after alkalization of the serum with NH₄OH. Chromatographic separation was achieved on a C 18 HPLC column with a mobile phase of acetonitrile and water containing 0.2% NH₄OH. Detection was performed in negative ion mode using multiple reaction monitoring (MRM) transitions of m / z 802.5 → 560.6 for tacrolimus and m / z 805.5 → 563.6 for the internal standard, tacrolimus‐ 13 C , d 2 . The calibration range for tacrolimus was 0.26–44.8 ng/mL. The method demonstrated good precision, with intra‐ and inter‐day relative standard deviations below 12%, and accuracy ranging from 94% to 103%. Compared to previously published methods, this approach requires only 200 μL of mouse serum and provides high sensitivity, with a lower limit of quantification of 0.26 ng/mL. The assay showed high sensitivity, minimal matrix interference, and good stability across tested conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mass Spectrometry Core Facility, Division of Basic Science & Transitional Research, Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, Texas, USA.
ORCID-Profile: Madhuri Tatiparthy, Ananth Kumar Kammala
Förderung
- NICHD NIH HHS
- NIH-NCATS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Wang, X., Tatiparthy, M., Thomas, T. J., Sama, V., Menon, R., & Kammala, A. K. (2026). Development and Validation of an LC–MS/MS Method for Quantitative Determination of Tacrolimus in Mouse Serum. Biomedical Chromatography, 40(5). https://doi.org/10.1002/bmc.70437
Vancouver
Wang X, Tatiparthy M, Thomas TJ, Sama V, Menon R, Kammala AK. Development and Validation of an LC–MS/MS Method for Quantitative Determination of Tacrolimus in Mouse Serum. Biomedical Chromatography. 2026;40(5). doi:10.1002/bmc.70437
BibTeX
@article{Wang2026,
author = {Wang, Xiaoming and Tatiparthy, Madhuri and Thomas, Tilu Jain and Sama, Vinoshana and Menon, Ramkumar and Kammala, Ananth Kumar},
title = {Development and Validation of an LC–MS/MS Method for Quantitative Determination of Tacrolimus in Mouse Serum},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {5},
doi = {10.1002/bmc.70437}
}
EUVIMED